Dressings

GBUK Group Limited is a UK-based medical device developer and distributor serving the NHS and global healthcare markets for over 16 years. The company designs, manufactures, and distributes a comprehensive portfolio of consumable and specialty medical devices across six core therapy areas: continence care, enteral feeding devices, patient handling, surgical & critical care, vascular access solutions, and wound management. Product offerings include IV cannulas, syringes, needle-free vascular solutions, enteral feeding bottles and adaptors, wound dressings and management supplies, patient handling equipment, and surgical consumables used in operating theatres and high-dependency units. GBUK reports 700,000 products used daily across healthcare settings. The company emphasizes technical excellence, innovation, and sustainability, with a commitment to low-carbon product delivery supporting net-zero healthcare initiatives. Manufacturing and distribution capabilities serve hospital systems, emergency departments, and home healthcare providers. All products are designed with clinical efficiency and patient comfort in mind. The company maintains an active presence at major UK and US healthcare conferences and events.

Kentron Health Care, Inc. is a medical products distributor and supplier based in Springfield, Tennessee, offering a comprehensive portfolio of medical consumables, disposables, and equipment. The company's product range includes syringes, needles, IV sets, wound care supplies (dressings, gauze, bandages), gloves, personal protective equipment (PPE), surgical instruments, diagnostic equipment, respiratory care products, sterilization products, germicidal products, and specialized kits for EMS, OB/GYN, and medical applications. Kentron supplies burn care products, cold/hot therapy packs, diabetic care supplies, infusion products (including the Kenaflexx line), immobilization devices, laryngeal products, nursing supplies, and urology consumables. The company also distributes hospital plastics, textiles, sharps containers, surgical tapes, tools, and miscellaneous medical supplies. Kentron serves emergency medical services, hospitals, clinics, and healthcare facilities across the United States. The company maintains MSDS (Material Safety Data Sheet) documentation for chemical products and operates as a B2B supplier with a full-service catalog spanning multiple therapeutic areas and clinical departments. Their product distribution model emphasizes accessibility to healthcare providers through direct sales and a comprehensive ordering system.

AVITA Medical is a therapeutic acute wound care company specializing in innovative technologies for thermal burn wounds, trauma wounds, surgical wounds, and full-thickness skin defects. The company's flagship product is the RECELL® System, an FDA-approved device that uses a small sample of the patient's own skin to create a suspension of Spray-On Skin™ Cells, prepared and applied at point-of-care. RECELL has been approved by the FDA for thermal burn wounds and full-thickness skin defects. AVITA Medical also holds exclusive US marketing, sales, and distribution rights for PermeaDerm®, a biosynthetic wound matrix dressing that adheres in a single application, and Cohealyx™, a collagen-based dermal matrix for full-thickness wound management. The company markets these products as optimizing wound healing and accelerating patient recovery times. AVITA Medical maintains certification to the AdvaMed U.S. Code of Ethics. The company has a robust pipeline exploring additional skin-related indications using its patented cellular technology platform. Recent announcements indicate FDA approval of the RECELL GO System and a 10-year BARDA agreement valued at $25.5 million for product development and supply.

Boston BGEcare Inc. is a Massachusetts-based medical consumables and contract manufacturing company specializing in wound care, personal protective equipment (PPE), compression garments, ostomy products, advanced wound care solutions, and operating room/surgical supplies. The company operates as both a direct product supplier and an original equipment manufacturer (OEM) partner, offering turn-key contract manufacturing services from product ideation through commercialization. BGEcare serves healthcare providers and manufacturers requiring transparent, efficient, and resilient supply chain solutions. The company maintains quality and regulatory compliance capabilities as core operational competencies, supporting FDA and other regulatory pathways. Product lines span traditional wound care (gauze, bandages, dressings), compression therapy systems, ostomy accessories, advanced wound management technologies, and surgical/OR consumables. BGEcare positions itself as a manufacturing partner for companies seeking to develop, scale, or outsource production of medical devices and consumables, emphasizing operational transparency and supply chain resilience.

Welly Health PBC manufactures consumer-grade wound care and first aid products marketed primarily toward children and active users. The company specializes in flex fabric adhesive bandages designed to remain secure during play and physical activity, available in decorative patterns and themed designs (e.g., Doggies, Flutter, Colorwash, Ice Cream, Glow Party). Product line includes hydrocolloid patches (blemish and bug bite relief), first aid wipes (alcohol-free and fragrance-free formulations), and comprehensive first aid kits (130-count). Welly bandages are positioned as premium consumer products that combine functional wound protection with child-appeal aesthetics. Products are distributed through direct-to-consumer e-commerce channels and major retail partners including Amazon. The company emphasizes play safety and infection prevention through its branding and product messaging, targeting families, schools, and active lifestyle consumers rather than clinical or institutional healthcare settings. No regulatory certifications (FDA 510(k), ISO 13485, CE mark) or clinical data are prominently featured on the website.

Boca Medical Supply is a durable medical equipment (DME) and supply provider serving Southern Florida since 1964. The company operates retail showrooms in the Boca Raton area and offers a comprehensive range of home medical equipment and consumables including mastectomy supplies (bras, swimsuits, prostheses, breast forms), lift chairs from brands like Pride and Golden Technologies, mobility devices (wheelchairs, walkers), bathroom safety equipment, compression therapy products, incontinence supplies, wound care products, orthopedic devices, and respiratory equipment. The company provides state-licensed orthotic fitting services and mastectomy fittings in addition to product sales. Services include equipment rentals, billing assistance, product education, and customer support. Products are distributed through two retail locations: Palmetto Park Square and Sandler Medical Plaza in Boca Raton. The company is accredited and positions itself as a full-service provider for post-surgery and mobility-related medical needs for home and community settings.

KX Medical is an FDA-registered contract manufacturer of single-use, disposable medical devices located in Gallatin, Tennessee. Operating a 30,000 sq ft facility, the company specializes in precision converting and custom medical device manufacturing with 30+ years of industry experience. Core product lines include advanced wound care dressings, continuous glucose monitoring components, remote patient monitoring devices, PPE for patients and caregivers, and IV dressings. The company serves large OEMs and medical device startups with engineering-focused solutions. Manufacturing capabilities include multi-station converting processes up to 13 inches wide with hyper-tight tolerances, inline multi-color flexographic printing, water-based and UV ink processing, Cognex video-controlled registration, Videojet lot coding, and slitting/rewinding services. Equipment includes 9-station and 7-station Delta Flex Crusaders and 16-inch wide 5-color flexographic printing systems. Quality and regulatory credentials include ISO 13485:2016 certification, FDA registration as a contract manufacturer, cGMP compliance, and CFR 820 adherence. UL Registered Firm with Certificate #35765.230523. The company emphasizes strong supplier relationships and custom solutions tailored to customer specifications.

Lavior Pharma Inc. manufactures botanical-based wound care and skin barrier products backed by 16 years of research. The company specializes in formulations derived from the Inula viscosa AGS-RIED plant species, combining botanical ingredients with clinical science for diabetic and general wound care applications. Primary product lines include hydrogel wound dressings, diabetic wound therapy gels, post-surgical skin barrier gels, and diabetic skin barrier creams in 1oz and 3.4oz formats. Products are formulated to support skin health, facilitate moist wound healing, and address diabetic skin complications including ulcer prevention and callus management. The company has achieved media visibility through coverage on ABC News, NBC News, CBS News, Fox News, and The CW. Lavior markets its products directly to consumers through e-commerce channels and positions formulations as alternatives to traditional ointments for both clinical and home care settings. The company maintains educational content addressing diabetic skin care, wound dressing techniques, continuous glucose monitor site healing, and footwear-related ulcer prevention. While specific FDA or ISO certifications are not explicitly detailed on the website, the emphasis on clinically backed formulations and 16 years of research development suggests regulatory compliance. Distribution and service capabilities appear focused on direct-to-consumer channels with newsletter and VIP club engagement models.

VastMed LLC is a U.S.-based manufacturer and supplier of disposable medical and dental supplies and durable equipment, headquartered in Grand Prairie, Texas. Founded on over 20 years of industry expertise, the company specializes in developing and producing high-quality consumables and equipment with emphasis on American standards and specifications. VastMed maintains an in-house R&D team of clinical professionals and design experts who conduct rigorous testing and validation of all products before market release. The company manufactures under proprietary brand names including Leone (gloves), TIGRIS (scented masks), Capra, Pitone, Pantera, and Piuma. Product portfolio spans medical disposables (gloves, masks, face shields, isolation gowns, lab coats, gauze, PPE, eyewear, sterile pouches), dental consumables (needles, syringes, cotton, bibs, hand instruments, impression materials), dental equipment (chairs, handpieces), laboratory supplies (specimen collection, testing kits), and durable medical equipment (hospital beds, wheelchairs). The company holds dealer networks across multiple states and actively participates in major dental and medical conferences. Quality assurance protocols include regulatory compliance, comprehensive testing and validation, detailed documentation and traceability, and continuous innovation in materials and design.

KM Supplies is a Los Angeles-based distributor specializing in traditional Chinese medicine (TCM) and acupuncture practice supplies. The company offers a comprehensive catalog of acupuncture needles, moxibustion products (loose moxa, preformed moxa, mini moxa, and moxibustion devices), cupping therapy equipment (glass, plastic, automatic, and fire cupping), and herbal medicine preparation tools including herb cookers, extractors, grinders, and pill makers. Product lines extend to electro and infrared heat therapy devices, massage supplies (massage units, gua sha tools, hot/cold therapy, oils and topical analgesics), and treatment room consumables such as gloves, sanitizers, wound care supplies, paper goods, and biohazard containers. The company also carries acupuncture accessories including press pellets, magnets, lancets, and bleeding needles. KM Supplies operates Monday to Friday from 9 AM to 5 PM PST and serves acupuncture practitioners, TCM clinics, and wellness professionals. The product portfolio targets both professional practitioners and treatment facilities requiring supplies for acupuncture, moxibustion, cupping, herbal medicine preparation, and general clinical treatment room operations.

Urgo Medical North America is the North American subsidiary of the French family-owned Urgo Group, specializing in wound care and skin management products for hospitals, nursing homes, and home health agencies. The company's focused portfolio includes clinically proven devices and solutions for wound cleansing, debridement, and management across acute and chronic care settings. Vashe® Wound Solution, their flagship product, is the #1 wound cleanser used in U.S. hospitals—a hypochlorous acid-preserved solution for intact and non-intact skin available in both professional and over-the-counter formulations. UrgoClean Ag is a charged-fiber dressing designed for continuous slough debridement. UrgoK2 provides a revolutionary dual compression system for consistent wound compression therapy. UrgoTul and UrgoTul Ag feature the TLC Restoring Matrix, a non-adherent contact layer that forms a lipidocolloid gel on wound surfaces. Drawtex® is a hydroconductive wound dressing with LevaFiber™ Technology that draws exudate away from the wound. VasheGel extends the Vashe product line. The company serves institutional and retail markets, with regulatory clearances appropriate for wound care consumables sold in the United States. Urgo Medical North America is headquartered in Fort Worth, Texas, and operates as part of a larger European medical device organization with established manufacturing and distribution capabilities.

United Health Products develops CelluSTAT™ Absorbable Hemostat, a biocompatible sterile gauze designed to assist in controlling bleeding when applied to cuts or open wounds. The product is currently under FDA Premarket Approval (PMA) review and is not yet available for commercial sale. The company focuses on innovative solutions for the management of complicated bleeds, positioning their hemostatic gauze as a wound-care consumable for surgical and emergency applications.

Carolina Narrow Fabric is a manufacturer of custom-designed specialty textiles and technical fabrics serving medical and industrial applications since 1929. The company specializes in fiberglass fabric and tape manufacturing in widths ranging from 0.25" to 120", including woven and warp-knit materials. For the medical sector, CNF supplies orthopedic casting materials and related textile solutions. The company operates through a dedicated medical division (CNF Medical) and maintains capabilities in fiber selection, knitting, weaving, and coating processes. Products are engineered for high-performance applications requiring thermal protection, structural reinforcement, electrical insulation, and specialized material properties. CNF serves aerospace, automotive, industrial, electrical, oil/gas, marine, military, and recreational markets alongside healthcare procurement.

Tiger Wound Care Medical, LLC is a science-driven wound care company specializing in tissue-based allograft products and wound dressings. The company develops and manufactures Cellular, Accellular, and Matrix-like Products (CAMPs) technology leveraging placental tissue for wound repair and tissue regeneration. Their core product portfolio includes dual-layer amniotic membrane allografts (collagen-rich, shelf-stable for 2 years) designed for standard wounds, and full-thickness placental membrane allografts (structurally supportive with native ECM characteristics, shelf-stable for 5 years) for complex wound environments. Additional offerings include the healPACK and carePAC wound dressing lines. Tiger Wound Care operates manufacturing and donor recovery facilities in Conshohocken, Pennsylvania and San Antonio, Texas, with capabilities in tissue processing and donor recovery. The company conducts ongoing randomized controlled trials (RCTs) to evaluate CAMPs technology effectiveness for nonhealing wounds and has submitted clinical data in connection with Medicare LCD (Local Coverage Determination) for skin products. All products are sterile and shelf-stable allografts intended for clinical wound care settings. The company serves hospital and outpatient wound care markets with science-backed solutions focused on supporting patient tissue repair and reconstruction.

North Coast Medical, Inc. is a B2B medical equipment and supplies distributor specializing in rehabilitation, physical therapy, and assistive devices. The company offers a comprehensive product portfolio including hand exercisers, therapeutic supports and orthoses (Comfort Cool Gladiator, OrthoThermic), electrotherapy and biofeedback equipment (EMG PRO Portable Biofeedback Stim Kit), therapeutic massage and compression devices (Normatec 3 Dynamic Air Compression Systems, Hypervolt 2, Venom 2 Heat & Massage Wrap), examination and treatment tables (Norco Beechwood Table, Norco 3-Section Hi-Lo Tables), mobility aids, and therapeutic accessories. The company manufactures and distributes branded product lines including Norco (furniture, protective equipment, cold packs), ActivaPatch (transdermal electrotherapy), HawkGrips (instruments and emollients), and carries third-party brands such as Normatec and Hypervolt. Products span physical therapy, occupational therapy, hand therapy, and orthopedic rehabilitation markets. North Coast Medical serves clinics, hospitals, and institutional buyers through direct sales and an e-commerce platform (myncmstore.com). The company provides practice management tools including RxCart (product recommendation software) and Control-Panel ordering system. Supported by professional associations including APTA, AOTA, and ASHT, indicating alignment with physical therapy and occupational therapy standards.

Berkeley Biologics is a tissue bank and contract manufacturer specializing in human allograft implants for orthopedics, spine, sports medicine, trauma, dental, and wound care. The company has 35+ years of expertise in tissue processing and transplantation. Core product lines include D-FIBER (demineralized cortical fiber matrix for bone regeneration), AcelloDerm (pre-hydrated acellular dermal matrix), AltiPly (lyophilized placental membrane for wound care), InteguPly (acellular dermis for sports medicine and wound repair), and TranZgraft (processed allograft tissues including tendons and ligaments for sports medicine). All products undergo rigorous donor screening, communicable disease testing, and quality assurance per AATB and FDA standards. Berkeley Biologics processes tissues using proprietary methods including low-dose e-beam irradiation and gamma sterilization to achieve sterility assurance level (SAL) of 10-6, while preserving native matrix structure, collagen integrity, and endogenous growth factors (BMP, FGF, IGF-1, PDGF, TGF-β). The company operates state-of-the-art manufacturing facilities in Northern California and offers turnkey contract manufacturing, private-label allograft opportunities, custom implant development, engineering and validation support, and inventory management services. Regulatory compliance includes FDA registration (21 CFR Parts 820 and 1271), AATB accreditation, and tissue bank licensure in California, Florida, Maryland, New York, Delaware, Illinois, Oregon, and Canada (CTO registration). The company serves surgeons, hospitals, and surgical centers across multiple specialties.

National Distribution & Contracting, Inc. (NDC) is a healthcare supply chain solutions provider headquartered in Nashville, Tennessee. The company operates through multiple business segments: a B2B distributor and manufacturer solutions division offering market intelligence platforms, supply chain optimization, 3PL services, master distribution, and business management solutions including contract and rebate processing; and Preferred Medical, a national wholesale distributor of medical supplies and equipment for infusion therapy and post-acute care markets. NDC serves over 450 manufacturer partners, 1,500 distributor and integrated delivery network (IDN) partners, and provides access to products for 6,800+ healthcare providers. Core capabilities include proprietary data analytics for competitive intelligence, group purchasing organization (GPO) services, vaccine buying groups, pharmaceutical sourcing for generic injectables, talent development programs, and marketing solutions. Preferred Medical specializes in distribution of IV therapy products, infusion pump services including repair, maintenance and rental, Wolf-Pak® brand consumables, and post-acute care supplies to home infusion pharmacies, infusion centers, ambulatory clinics, and long-term care facilities. The company provides scalable warehousing, fulfillment, and regulatory support infrastructure. NDC operates as a master distributor enabling manufacturers to access wide provider networks and independent distributors to leverage shared scale and national brand access.

Smith & Nephew is a global medical technology company specializing in the repair, regeneration, and replacement of soft and hard tissue. Founded in 1856, the company operates across four key business divisions: Orthopaedics, Sports Medicine, Advanced Wound Management, and ENT (Ear, Nose, and Throat). The Orthopaedics portfolio includes hip and knee implants, trauma products, robotics-assisted surgery systems, and instruments for fracture stabilization and bone deformity correction. The Sports Medicine division offers minimally invasive surgical solutions for soft tissue repair and degenerative conditions affecting the shoulder, knee, hip, and small joints. Advanced Wound Management provides comprehensive solutions for acute and chronic wounds including leg ulcers, diabetic ulcers, pressure ulcers, burns, and post-operative wounds, featuring negative pressure wound therapy systems and advanced dressings. The ENT portfolio encompasses products for epistaxis, laryngeal reduction, septoplasty, turbinate reduction, sinus surgery, and tonsil/adenoid removal. With presence in over 35 countries and a commitment to clinical education through S+N Academy centers and online platforms, Smith & Nephew serves healthcare professionals globally.

Global WholeHealth Partners Corp (GWHP) develops and markets SilverStream, an innovative wound care solution designed to accelerate the healing process for chronic, infected, and non-infected wounds, burns, and surgical site infections. The product is available in both over-the-counter and prescription formulations and is marketed as safe as OTC but effective as Rx. SilverStream is distributed to hospitals, clinics, nursing homes, and home health agencies. The company emphasizes superior biofilm destruction with logarithmic reduction >7.3 and evidence-based wound management protocols. GWHP also operates a companion brand, SilVet, which provides wound healing solutions for veterinary and animal care applications. The company's product portfolio supports treatment and management of wounds, burns, surgical site infections, and skin integrity challenges across human and veterinary markets.

NeXtGen Biologics, Inc. is a medical device company specializing in regenerative medicine and scar-free wound healing solutions. The company's proprietary technology leverages extracellular matrix (ECM) derived from the axolotl, a salamander renowned for its remarkable regenerative abilities without scarring. NeXtGen's flagship product, NeoMatriX® Wound Matrix, is a collagen-based medical device engineered to support partial and full-thickness wound management in clinical settings. NeoMatriX is available in sheet formats with room-temperature storage capability, offering cost-effective wound care with demonstrated clinical efficacy in applications including post-surgical wounds, diabetic foot ulcers, and Mohs surgery closures. The company is positioned to expand its product pipeline within the North American market, targeting healthcare professionals in wound care and neuromusculoskeletal regeneration specialties.

ABL Medical, LLC is a medical-grade silver products manufacturer specializing in advanced wound care solutions powered by proprietary Hydronanon Technology®. The company develops and distributes SilvrSTAT, a multivalent catalytic nanoparticulate molecular silver wound dressing gel with demonstrated antimicrobial efficacy against bacteria, antibiotic-resistant strains, and fungi. SilvrSTAT is indicated for management of burns, ulcers, skin tears, donor sites, graft sites, insertion sites, and incision sites. With over a decade of clinical partnerships with healthcare professionals, ABL Medical combines decades of silver technology research with evidence-based formulations to deliver infection control and enhanced patient outcomes in wound management without known adverse reactions.

Sol-Millennium Medical Group is a global healthcare manufacturer and distributor headquartered in Chicago, Illinois, with origins in precision plastic molding dating to 1982. Founded as a medical device company in 2006, Sol-Millennium specializes in design, manufacturing, and distribution of safety-engineered medical devices and personal protective equipment. The company is recognized as one of the world's largest manufacturers of needles and syringes. Product portfolio includes safety-winged infusion sets (Sol-Care™), safety syringes, safety needles, blood collection devices, insulin delivery systems including the InsuJet™ needle-free delivery system, diabetes care products, wound care dressings, and comprehensive PPE offerings. The company maintains a strong global presence with offices in Shanghai, Chicago, São Paulo, and Warsaw, with manufacturing and R&D capabilities distributed across regions. Sol-Millennium is committed to healthcare worker safety through innovation in safety-engineered sharp devices and advancing patient care through high-quality medical consumables.

AMPARO Medical Technologies is a manufacturer and formulator of medical-grade hydrocolloid adhesives headquartered in Anaheim, California. The company specializes in custom-formulated hydrocolloid products for medical device attachment, wound care, ostomy, catheter securement, negative pressure wound therapy (NPWT), and cosmetic applications including acne patches. All manufacturing is conducted in-house at the Anaheim facility using raw materials sourced from the USA and Europe. The company's hydrocolloid formulations are engineered to provide superior adhesion to moist skin, high absorbency, and non-skin-sensitizing performance—characteristics that have made hydrocolloid the gold standard in wound care and ostomy for over 50 years. Products can be customized with active ingredients for pain relief, drug delivery, and therapeutic applications. AMPARO's Quality Management System is ISO 13485:2016 accredited by BSI, and all formulations are compliant with ISO 10993 biocompatibility standards, EU REACH and RoHS regulations, and California Proposition 65. The company offers master roll manufacturing with configurable performance characteristics (adhesion, absorption, modulus), physical dimensions (width, thickness, single or double-sided), and component selections (polyurethane or polyethylene film carriers; polyester or paper release liners). Services include design development, technical consultation, and 100% product verification testing conducted by the company's in-house testing laboratory.

MLM Biologics Inc. is a Delaware C-Corporation that develops and manufactures advanced wound care solutions based on proprietary collagen scaffold technology. The company's flagship product is bio-ConneKt® Wound Matrix, an FDA-cleared, sterile collagen-based wound closure device indicated for a broad range of acute, chronic, trauma, surgical, and burn wounds, including diabetic foot ulcers, venous ulcers, and pressure ulcers. bio-ConneKt® is manufactured in an ISO 13485-certified facility and holds reimbursement coding (HCPCS Level II Q-code) from the Centers for Medicare and Medicaid Services. The company employs a proprietary processing platform based on expertise in scaffold chemistry and biology to deliver cost-effective, clinically proven solutions for wound closure. Product features include user-friendly storage, extended shelf-life, point-of-use application, and compatibility with negative pressure wound therapy (NPWT). MLM Biologics also pursues complementary development in sports medicine, orthopedics, and general surgery. As of December 2023, BioWound Solutions acquired exclusive US sales and marketing rights to bio-ConneKt®. The company has received significant recognition, including nearly $1.5 million in funding from the U.S. Army Medical Research and Development Command (USAMRDC) for development of infection-prevention devices for battlefield wounds.

Dealmed Medical Supplies LLC is a B2B medical supply distributor serving physicians, healthcare facilities, surgical centers, urgent care, dialysis facilities, health systems, emergency medical services, and retail channels across the United States. The company operates as an authorized distributor for nearly 300 brands, offering a comprehensive product portfolio spanning medical and surgical consumables, medical and office equipment, physician laboratory supplies and diagnostics kits, office management supplies, and pharmaceuticals. Product lines include examination gloves (nitrile), surgical gauze sponges, adhesive bandages, surgical tape, suture and staple removal kits, examination tables, patient monitoring systems (Welch Allyn Connex Spot Monitor), spirometers (NDD EasyOne Air), clinical laboratory analyzers (Diatron Abacus, Quidel Sofia), rapid diagnostic tests (Strep A, COVID-19 antigen, influenza), steam sterilizers (Midmark M11), drape sheets, table paper, emesis basins, underpads, and injectable pharmaceuticals including naloxone, calcium chloride, diphenhydramine, aspirin, and cyanocobalamin. Dealmed operates multiple distribution centers leveraging proprietary logistics technology to enable fast fulfillment through its own fleet and major carriers. The company provides Dealmed Runtime™, a proprietary online ordering and management platform offering automatic reporting, inventory alerts, and supply chain visibility. Services include GPO contract integration, 3PL capabilities, custom shipping solutions, and consultative procurement support. Dealmed markets itself on operational agility, guaranteed product authenticity and warranty coverage, and omnichannel distribution reach. Founded in 2008, the company serves diverse care models from individual practices to large integrated delivery networks and government/public sector entities.

Tides Medical is a regenerative medicine company headquartered in Lafayette, Louisiana, specializing in human amniotic tissue allografts for chronic wound care and surgical applications. The company sources and processes donated placentas through Louisiana Organization for Transplant (LOFT), a Tides Medical division, to manufacture advanced skin substitute products. Processing occurs in-house at their ISO Class 6 Cleanroom tissue bank in Lafayette, with terminal sterilization via radiation in compliance with FDA guidance and AATB standards. Product lines include Artacent Flex, Artacent Connect, Artacent AC, Artacent Ocular, and AmnioHeal Plus, all designed for room-temperature storage up to 5 years post-manufacturing and requiring no sutures for application. Tides serves physicians and surgical centers nationwide with a dual-channel distribution model: direct sales for advanced wound care and a separate APLICOR 3D division for 3D bioprinting systems. The company provides comprehensive reimbursement support, coding assistance, and audit defense services to remove barriers to patient access. Leadership includes CEO Joe Spell (founder), COO Doug Payne (15+ years regenerative medicine experience), and VP of R&D Dr. Mora Melican (30+ U.S. patents in medical devices and biomaterials; formerly Johnson & Johnson). Currently registered and accredited through March 2028.

Asclepii Inc. is a US-based medical device company specializing in regenerative medicine and advanced wound care solutions. The company develops FDA-cleared nanosilver hydrogel wound dressings designed to support moisture balance and accelerate wound healing while preventing infection. Asclepii's flagship product, Poseidon™ Nanosilver Hydrogel, utilizes proprietary nanotechnology to deliver antimicrobial silver at ultra-low concentrations (1 ppm versus 30–10,000 ppm in competitors) without contributing to antibiotic resistance. Clinical studies demonstrate 96% infection-free outcomes within 8 days, outperforming leading silver dressings. The company serves clinics, providers, distributors, and resellers with scalable wound care technology designed for accessibility and clinical efficacy in everyday practice. Asclepii is developing next-generation bioengineered regenerative scaffolds for chronic and complex wound management.

NEXGEL, Inc. is an FDA-registered, ISO-certified manufacturer of advanced hydrogel transdermal delivery systems. Originally developed and FDA-approved for hospital wound care, the platform now serves OTC medications, prescription pharmaceuticals, medical devices, and cosmetic applications. The company operates a 16,500 sq ft cGMP manufacturing facility with R&D and converting capabilities, offering flexible hydrogel formulations with or without active ingredients. Products include four proprietary hydrogel platforms—Arctic5 (94.5% water content for cooling/soothing), Arctic10 (90% water for versatile delivery), Synapse (55% water for long-wear adhesive patches), and Mother Earth (biodegradable, paraben-free formulation). Applications span wound care, OTC health patches, beauty/skincare, foot care, pain relief, and custom ingredient delivery for sensitive skin.

QMed is a wholesale medical, surgical, dental, and laboratory product distributor serving health systems, ambulatory surgical centers, physicians' offices, urgent care facilities, emergency medical services, and post-acute care providers throughout the United States and internationally. Operating from an ISO-certified 180,000+ square foot distribution center, QMed maintains over 11,000 individual SKUs including advanced wound care, respiratory equipment, IV therapy supplies, diagnostic instruments, orthopedic products, sterilization equipment, and infection control supplies. Since 1990, the company has partnered with national distributors, regional independents, and retailers to optimize supply chain efficiency, reduce total cost of goods, and enhance product portfolios through world-class sourcing capabilities and deep healthcare industry expertise.

Focus Health Group is a Knoxville, Tennessee-based pharmaceutical and specialty medical products distributor. The company manufactures and supplies cost-effective, high-quality specialty healthcare products distributed through major pharmaceutical wholesalers including McKesson, Cardinal Health, Medline, and Henry Schein. Core offerings include advanced wound management systems (ZeniCOL collagen dressings, ZeniFOAM, ZeniGEL, ZeniABSORB calcium alginate dressings), topical anesthetics (AneCream®, AneCream5®), epinephrine emergency kits with RFID-enabled product labeling for dental and anaphylaxis management, and specialty pharmaceutical ingredients. The company holds Drug Distributor Accreditation from the National Association of Boards of Pharmacy and emphasizes lean manufacturing, regulatory compliance, and operational efficiency to deliver value across the healthcare continuum.

Coloplast A/S is a Denmark-based multinational manufacturer of intimate healthcare solutions serving 2 million+ patients across 100+ countries. The company specializes in six primary care areas: Ostomy Care (pouching systems and related products for colostomy, ileostomy, and urostomy patients); Continence Care (intermittent catheters and urinary collection devices); Interventional Urology (implants, surgical slings, and urology instruments); Bowel Care (transanal irrigation systems for bowel management); Wound & Tissue Repair (advanced wound dressings and biologic products); and Voice and Respiratory Care (voice prostheses, heat and moisture exchangers, tracheostomy tubes, and adhesives). Coloplast manufactures and distributes medical devices and consumables directly and through distributors in markets where subsidiaries are not established. The company operates customer care centers globally and provides comprehensive support services through Coloplast Care (patient support and education) and Coloplast Professional (healthcare provider training and clinical resources). Products are designed with user-centered innovation informed by patient feedback. The company maintains regulatory compliance across major markets and serves hospitals, clinics, home care settings, and individual patients. Coloplast is publicly listed on the Copenhagen Stock Exchange (ticker: COLO B).

Human BioSciences, Inc. (HBS) is an FDA-regulated biotechnology manufacturer specializing in proprietary collagen-based wound care products. Founded in 1996 and headquartered in Gaithersburg, Maryland, HBS develops, manufactures, and distributes advanced wound healing solutions utilizing its proprietary Kollagen™ technology—100% native, non-hydrolyzed Type I bovine collagen engineered to support all four phases of wound healing. The company's core product portfolio includes SkinTemp® II collagen dressings, Medifil® II collagen particles, and Collatek® collagen gel, indicated for burns, diabetic ulcers, surgical wounds, and chronic wounds. HBS also manufactures veterinary collagen products under the Kollavet™ brand. Beyond branded products, HBS operates a full contract manufacturing division offering private label production, custom formulation, and contract research services (including 510(k) and PMA submissions) for medical-device and consumer-product manufacturers. The company serves hospitals, wound care clinics, healthcare professionals, and veterinary practitioners through a global distribution network and maintains in-house clinical education and regulatory expertise.

Hydrofera is a manufacturer of advanced foam wound dressings under the Hydrofera Blue product line. The company specializes in non-cytotoxic antibacterial foam dressings designed to create a balanced wound bed environment that promotes epithelialization while managing exudate and reducing bioburden. The Hydrofera Blue product suite includes four main variants: Border (silicone adhesive border for atraumatic changes), Classic (flagship multifunctional foam with antibacterial properties), Ready (extended wear time up to 7 days with reduced dressing changes), and Transfer (higher exudate absorption). These dressings are indicated for wound healing across multiple patient populations. All Hydrofera Blue products utilize proprietary non-toxic antibacterial foam technology designed to maintain moist wound environments while wicking debris. The company maintains a direct sales organization with regional representatives and serves acute care, wound care centers, and institutional healthcare settings.

Web-Tex, Inc. is a family-owned manufacturer of medical bandages, surgical dressings, and orthopedic supports with over 35 years of industry experience. The company produces and supplies more than 500 different types of bandages and support products distributed through major hospitals, medical facilities, and large U.S. retailers as private-label offerings. Product lines include wrist, ankle, elbow, knee, and back supports; general bandages and first-aid supplies; medical tapes; absorbent pads; and hot and cold therapeutic packs. Web-Tex offers custom development and manufacturing services for OEM partners seeking private-label bandages, dressings, and orthopedic support products. The company serves hospital procurement, retail pharmacy chains, and medical supply distributors across the United States.

Trademark Medical, LLC is a medical consumables and specialty products distributor headquartered in the St. Louis, Missouri area. The company specializes in oral care products, wound care supplies, casting and bandaging materials, anesthesia-related products, and orthopedic/podiatry items. Their product portfolio includes bioXtra Oral Moisturizing Gel (for xerostomia management), neonatal oral therapy kits, adult and pediatric oral care kits, pill crushers (personal and institutional table-top models), wound-measuring guides, cast covers, shower-safe dressing covers, and oral care accessories. The company serves both personal-use and professional institutional markets, including healthcare facilities, neonatal units, and patient care settings. Products are designed for application in oral hygiene, infection control, patient comfort, and medication administration support. Trademark Medical maintains a B2B e-commerce platform and direct sales infrastructure to support hospital systems, clinics, and individual consumers. No specific regulatory certifications (FDA 510(k), ISO 13485) are mentioned on the current website, though the product range and market positioning suggest compliance with standard medical device regulations.

KeraNetics, Inc. is a medical device company founded in 2008 in Winston-Salem, North Carolina, specializing in keratin-based topical treatments for radiation-induced skin injury. The company's flagship product is KeraStat® Cream, an FDA-cleared prescription topical cream designed for the management of radiation dermatitis in patients undergoing radiotherapy for head, neck, throat, skin, and breast cancers. Radiation dermatitis affects an estimated 95% of the 4 million Americans receiving radiation therapy annually, presenting with symptoms including erythema, soreness, pigmentation changes, pruritus, desquamation, blistering, ulceration, and necrosis. KeraStat® Cream harnesses keratin proteins to provide symptomatic management and is indicated for both prophylactic (preventative) use following the first radiation dose and therapeutic management of established radiation burns. The product is available in two formulations: a 1-ounce tube for radiation dermatitis and a 5-milliliter tube for general wound care. KeraStat® is a prescription product processed through major electronic medical record systems such as Epic and distributed via specialty pharmacies including ASPN Pharmacies. The company has received significant federal recognition, including a $3.5 million contract from the Biomedical Advanced Research and Development Authority (BARDA) for cutaneous radiation injury management. KeraNetics' origins trace to partnerships with the Wake Forest Institute for Regenerative Medicine and include experience addressing battlefield traumatic injuries, reflecting a clinical focus on regenerative wound care solutions.

MedDev is a healthcare technology company specializing in regenerative medicine and advanced wound care solutions. The company distributes biologic skin substitutes based on amniotic membrane technology, designed to accelerate healing in chronic wounds, burn wounds, ophthalmic applications, and surgical procedures. Their product portfolio includes multiple branded skin substitute lines (XCell, XCellerate, Royal Wound, Precise, Royal Bio, BioLab, DermMax, and EnColl). Beyond product distribution, MedDev provides integrated practice optimization services including revenue cycle management, workflow efficiency enhancement, administrative burden reduction, and scheduling optimization. The company serves healthcare providers, clinical partners, and distributors across the United States. MedDev's regenerative solutions leverage amniotic membrane grafts containing growth factors and cytokines to promote cell proliferation, tissue regeneration, inflammatory modulation, and minimal immune response. The company emphasizes compliance-first operations, clinical research backing, and hands-on provider support. Their business model combines premium biologic products with comprehensive practice management services to optimize both patient outcomes and provider operations.

MTF Biologics is a not-for-profit tissue bank and allograft processor founded nearly 40 years ago and originally established by orthopedic surgeons. The company processes and distributes human allograft tissues for clinical applications across orthopedic surgery, plastic and reconstructive surgery, soft tissue reconstruction, and advanced wound repair. Core product lines include bone allografts, cartilage allografts, meniscal allografts, fresh osteochondral allografts, soft tissue grafts, and dermal allografts for burn and chronic wound management (diabetic foot ulcers, venous leg ulcers, sacral ulcers, tunneling wounds). MTF Biologics employs aseptic processing without terminal radiation or harsh chemicals, claiming to be the only U.S. tissue bank using 100% aseptic processing methodology. This approach preserves natural tissue structure and biological properties. The company operates a fully-digital graft matching platform allowing surgeons to upload imaging, receive anatomical matching confirmation, and streamline surgical planning. MTF Biologics maintains an international division with a global network of partners, agents, and distributors. The company has distributed over 12 million grafts to date without documented cases of viral disease transmission. Regulatory compliance and donor screening exceed industry standards. The organization provides continuing medical education (CME) to healthcare professionals. As a not-for-profit entity, MTF Biologics focuses on patient outcomes, research advancement, and grantmaking to support tissue transplantation science.

Alliance Healing Technologies, LLC (ALHT) is a wound care medical device and digital health company specializing in chronic wound management. The company holds exclusive rights to the Acutarex™ PDR 60 Healing System, a proprietary, FDA 510(k)-cleared advanced wound care solution employing Proteinase Down Regulator (PDR) technology. The Acutarex PDR 60 system combines medicated healing bandages (PDR-impregnated), wound prep spray, and the Wound Care Connection app—a HIPAA-compliant digital platform enabling seamless daily communication and photo documentation between patients and providers. Clinical evidence supports 75–95% healing rates within 60 days across wound types including diabetic foot ulcers, venous ulcers, pressure ulcers, and refractory Grade IV ulcers; 100% of Grade II and III ulcers achieved complete healing in under six weeks. The system integrates treatment adherence tracking, automated progress records, and provider notifications. ALHT is HIPAA-compliant and implements secure data handling for Protected Health Information. The company maintains global expansion plans for 2026 in the US, Saudi Arabia, Colombia, and Panama. Manufacturing and distribution capabilities support both direct clinical and patient-home applications.

Surgyco LLC is a Puerto Rico-based medical consumables and equipment supplier founded in 2005. The company manufactures and distributes a comprehensive range of surgical and medical products to hospitals, government agencies, emergency clinics, doctor offices, and clinical laboratories across public and private sectors globally. Primary product lines include syringes and needles (FDA-approved, manufactured at high efficiency), bandages, gauzes, and wound care dressings. Surgyco also supplies anesthesia equipment, respiratory therapy products, personal protective equipment (PPE), medical-surgical products, procedure trays, and chest drainage systems and tubes. The company emphasizes safety, quality, and inventory availability with rapid order fulfillment capabilities. Manufacturing processes are FDA-approved and comply with regulatory standards. Surgyco positions itself as a quality-focused supplier with commitment to ethical business practices, customer-centric service delivery, and sustainable healthcare solutions. The company serves diverse healthcare settings from acute care to clinical diagnostics.

Bio Med Sciences, Inc. is a medical device manufacturer founded in 1987 specializing in advanced wound care, scar management, and skin renewal products. Headquartered in Allentown, PA, the company develops proprietary Silon® technology, a patented blend of silicone and PTFE (Teflon®) that enables production of innovative semipermeable membranes and thin-film dressings. The company holds over 60 patents and operates an FDA-registered, ISO-compliant manufacturing facility. Product lines include Silon-TSR® (advanced wound dressing), Dual-Dress 50® (multi-layer foam dressing), Rylon-1® (wound care), and Silon® scar management products for professional healthcare providers. Consumer brands include Oleeva® (retail scar management) and SeaAllure™ (skin-firming patches for wrinkle reduction). Bio Med serves burn treatment, dermatology, plastic surgery, long-term care, and rehabilitation markets. The company manufactures custom medical devices and offers contract R&D services in skin adhesive systems and thin-film production. In June 2021, Bio Med relocated to a 999 Postal Road facility (tripled space; doubled production capacity). The company has partnered with the U.S. Army Institute of Surgical Research (CRADA) on antimicrobial wound dressing development and sells through authorized distributors and direct consumer channels.

Advanced Medical Solutions Group plc (AMS) is a world-leading independent developer and manufacturer of innovative tissue-healing technologies serving surgical, wound care, and specialty medical markets globally. The company operates 14 manufacturing and R&D locations across Europe, Asia, and other regions, with >1,500 employees and distribution partnerships in >90 countries. Core product lines include: (1) Surgical—adhesives and sealants for internal wound closure, biosurgicals (collagen-based hemostats and regenerative products), and sutures and related supplies; (2) Wound Care—exudate management systems, infection control dressings, and other advanced wound technologies including hydrogels. AMS also operates a dental division and contract manufacturing services. Key subsidiary and acquired brands include RESORBA (biosurgicals and sutures, Nürnberg and Domazlice), Raleigh Adhesive Coatings (woundcare coatings, Stafford), ActivHeal (wound care brand), Peters Surgical (clips and sutures, Domalain France; suture manufacturing in Thailand and India), Catgut GmbH (sutures, Markneukirchen), and Connexicon Medical (tissue adhesives R&D, Dublin). Manufacturing capabilities span bulk foam roll-stock, collagen processing, suture extrusion, and specialized coatings and formulations. The company is listed on the London Stock Exchange (LSE), with FY24 revenue of £177.5M and adjusted profit of £29.4M. Regulatory standing implies FDA, ISO 13485, and CE mark compliance across product portfolio, though specific certifications are not detailed on fetched pages. AMS positions itself as a surgical powerhouse and leader in tissue regeneration and hemostasis.

POSS LLC is a medical supplies distributor based in Tallahassee, Florida, specializing in consumables, disposables, and homecare equipment. The company offers an extensive inventory of clinical-grade products including sterile and non-sterile gauze sponges (2x2, 3x3, 4x4 in various ply counts), nitrile gloves (multiple sizes and thicknesses), surgical gowns (AAMI Level 3 compliant), bouffant caps, alcohol prep pads, underpads, specimen containers, urinary drainage bags, field drapes, suture removal kits, sharps containers, emesis bags, Foley catheter trays, and IV catheters. The company also distributes homecare equipment including walkers, bedside commodes, foam mattresses, and overbed tables. POSS carries multiple trusted brand lines alongside proprietary POSS-branded products. The company emphasizes affordable pricing with premium-quality merchandise, personalized customer service, and same-day or next-day local delivery in the Tallahassee area. Product sourcing includes partnerships with established medical manufacturers such as Dynarex, Assure, IMCO, and others. The business model focuses on B2B supply to healthcare facilities, clinics, and homecare providers requiring reliable, cost-effective access to consumables and basic equipment without premium markups.

Remedium Healthcare Products is a skin and wound care solutions provider serving hospitals, care facilities, and home care settings. The company operates through two primary brands: Nuveria Labs, which manufactures high-tech wound care bandages and dressings combining advanced materials with cutting-edge technology for accelerated healing across various skin concerns; and Skincentry, which offers formulated skincare products designed to nourish, protect, and rejuvenate skin. The company emphasizes affordable, advanced solutions paired with comprehensive clinical education and support. Product offerings span wound care management for multiple wound types and skincare solutions for diverse skin conditions. Remedium Healthcare Products provides targeted education resources covering wound care protocols, skin type assessment, and condition-specific product recommendations for healthcare providers and patients. The company serves acute care, post-acute care, and home healthcare markets. Based in Northbrook, Illinois, the company positions itself as a provider of clinically-guided, innovation-focused skin and wound care with emphasis on healing outcomes and accessibility across the healthcare spectrum.

ProMed Health Plus is an HQAA-certified advanced wound care provider specializing in bundled clinical kits and collagen-based dressing products. The company manufactures and distributes ProPack™ Clinical Bundles—curated 30-day wound treatment cycles—and Collagen Collection clinical sheets (pure bovine collagen matrices) designed for chronic and stagnant wound healing. Products are HCPCS-coded and reimbursement-optimized. ProMed serves three core market segments: (1) physicians and wound care centers via in-office dispensing programs with dedicated account management; (2) home health providers and patients through clinician-guided care, education, and direct-to-home delivery; and (3) facilities and distributors through wholesale arrangements with Net 30 terms and custom kit configurations. The company provides comprehensive support including ICD coding guides, reimbursement navigation, product samples, and live clinical support. Manufacturing and distribution capabilities support SNFs, DMEs, and wound care facilities across the US.

Monarch Labs is the leading US manufacturer and distributor of Medicinal Maggots™ (disinfected Phaenicia sericata larvae) for advanced biotherapy wound care. Founded in 2005, the company has served over 3,000 customers across the continental United States. Medicinal Maggots™ are FDA-regulated prescription-only medical devices indicated for treatment of pressure ulcers, venous stasis ulcers, neuropathic foot ulcers, and non-healing traumatic or post-surgical wounds. The larvae debride necrotic tissue through enzymatic action, promoting autolytic wound healing without systemic toxicity. Products include standard Medicinal Maggots™, LeSoc™ dressings, Sheer Comfort™ dressings, and Maggot MegaPak configurations. All products are designed and manufactured in the USA. Monarch Labs provides comprehensive reimbursement support, coordinating coverage with Medicare, Medicaid, DVA, and private insurers. The company serves patients, wound care therapists, and veterinarians, offering educational resources including the Maggot Therapy Talks webinar series led by Dr. Damon Carbonaro. Customer support includes clinical guidance on application procedures, a three-step application process utilizing specially constructed dressings, and assistance navigating insurance authorization. The therapy has historical precedent dating to the American Civil War and contemporary validation in institutional settings including academic medical centers.

Tricol Biomedical is a fully integrated medical device company specializing in hemostatic and wound-care management solutions. The company develops and markets the HemCon product line, built around its proprietary chitosan technology (Chito+), designed to enable rapid bleeding control across three primary market segments: Trauma Management, Procedural Care, and Consumer Self-Care. Founded with a legacy tied to battlefield medicine (original 2001 partnership with U.S. Army), Tricol's hemostatic dressings utilize a polycationic charge mechanism that promotes binding with negatively charged tissue biopolymers to facilitate rapid hemostasis and enable the body's natural coagulation pathway. The product portfolio includes HemCon PRO dressings (trauma and procedural settings), OneStop Bandage (rapid bleeding control including patients on anticoagulants), ChitoGauze (minor wound bleeding control), and ChitoDot bandages (procedural puncture site management). Applications span pre-hospital and battlefield trauma, hospital procedural care (angiography, dialysis access, surgical hemostasis), dental surgery, and over-the-counter consumer first-aid use. The company serves military, emergency medicine, hospital procedural areas, dialysis centers, and direct consumers. Tricol maintains manufacturing and headquarters operations in Portland, Oregon, with a European subsidiary (HemCon Medical Technologies CZ) in the Czech Republic. The company emphasizes quality, innovation in bleeding control technology, and maintains sample evaluation programs for facility and medical professional assessment.

Saferlife Products Co., Ltd. is a manufacturer of disposable medical products, healthcare goods, and first-aid supplies founded in 2009. Operating from a 1000+ square meter facility in China, the company specializes in portable and tactical first-aid kits, medical tapes and bandages, CPR masks and resuscitation devices, pill dispensers, homecare medical supplies, and emergency response equipment. Product lines include travel first-aid kits, tactical IFAK (Individual First Aid Kits) pouches, portable first-aid kit boxes, medical-grade adhesive tapes (kinesiology and sports tape variants), waterproof dressing covers, emergency stretchers, AED trainer units, and medical training manikins. The company holds ISO 13485, CE, and American Standard certifications. Manufacturing capabilities include custom development, assembly, and logistics support with FOB, CIF, DDU, and DDP shipping options. Markets served include emergency response, sports medicine, home healthcare, outdoor/tactical use cases, and medical training institutions. The company maintains quality control through advanced automated machinery and in-house testing laboratory.

Ultra Wound Care LLC manufactures and distributes DermaHug, an advanced wound care stabilization device designed to secure dressings without tape. The DermaHug is a flexible, reusable silicone-based device featuring a thick silicone gel layer and brushed nylon surface that provides controlled compression to wound margins while preventing dermal stripping and contact sensitivity reactions. The device is hydrophobic, allowing continuous wear for two weeks or longer, and can be worn during bathing or showering. It is hand-washable with mild soap and water, adjustable, removable, and reapplicable without leaving residue. The DermaHug serves as both a primary and secondary dressing for complex wounds, including post-surgical incisions, dehisced wounds, open abdomens, EC fistulas, diabetic foot ulcers, and difficult-to-heal wounds. The device can be trimmed to fit patient-specific needs and accommodates cannulas, catheters, and ports. Ultra Wound Care emphasizes improved patient comfort and satisfaction, reduced incidence of dehiscence, decreased skin stripping complications, and cost-effectiveness through extended wear cycles and reduced dressing change frequency. The company provides clinical consultation through certified wound care specialists with extensive clinical experience. Products are hypoallergenic, latex-free, and designed with optimal moisture vapor transmission rates to support the wound healing environment.

Core ProMed Supplies is a B2B medical supplies distributor serving hospitals, clinics, and home care settings with a focus on wound care and durable medical equipment. The company operates an online platform offering comprehensive wound care solutions, enteral nutrition products, pharmacy supplies, protective equipment, and surgical instruments. Core ProMed stocks major brand lines including ALMORIS, Medline, McKesson, Cardinal Health, Hartmann, and Derma Rite. Product portfolio emphasizes advanced wound care dressings (foam with silicone borders, alginate, silver-impregnated, super-absorbent), gauze sponges (sterile and non-sterile, various ply levels and materials), bordered gauze island dressings, wound cleansers, medical tape, and related wound management supplies. The company provides Medicare Part B and Medicaid billing support, working directly with HMOs and other insurance carriers for streamlined verification and reimbursement. Core ProMed offers guided 30-day dressing protocols tailored to Medicare and HMO beneficiary needs, prioritized insurance verification prior to delivery, and auto-delivery subscription options with 5% savings. Free shipping threshold is $299 for orders within the contiguous United States. The company serves as a medical supply distributor with logistics capabilities supporting on-time delivery for institutional and home care markets.

Pharmaplast is a global manufacturer and distributor of wound care, surgical, and medical consumables. The company operates 85 production lines and maintains warehouses, microbiology, quality assurance, and quality control departments. Primary product categories include advanced wound care (hydrogels, hydrocolloids, foams, alginates, silicone dressings), surgical dressings (post-operative, non-adherent pads, deodorizing), medical adhesive tapes (sports, silicone, fixation), anti-microbial wound care (silver and iodine-based products), cannula and tube fixation systems, casting and bandage materials, first-aid bandages, gauze and swabs, incise and surgical drapes, ostomy care products, foot care solutions, tubular net bandages, PPE (gowns, masks), and pain relief products (ice packs, thermal patches). The company also supplies raw materials including non-woven fabrics, films, fibers, and molded components to medical device manufacturers. Key branded product lines include Pharmapore®, Pharmacoll®, Espuma®, AbsoClear®, Cavidagel®, Flexinet, Synocast, and Insola. Facilities include microbiology testing and quality control departments. The company exhibits at major trade shows including Hospitalar and PLMA, indicating established B2B distribution channels.

Core Scientific Creations Ltd manufactures WoundClot Advanced, a next-generation hemostatic gauze for bleeding control across surgical, emergency, and perioperative settings. The product is engineered from non-oxidized, non-regenerated cellulose (NONRCS) that converts to a thick, tenacious 3D gel matrix upon contact with blood. WoundClot offers rapid hemostasis through four mechanisms: absorption (up to 2,500% of weight in blood, active for 24 hours), aggregation of platelets and clotting factors, adhesion to wound tissue without dislodgement during movement or high-pressure bleeding, and activation of clotting factors (PTA XI and Hageman XII). Unlike kaolin and silica-based alternatives, WoundClot does not cause rebleeding when removed, does not leach particles, and requires no compression or packing for efficacy. The company markets to hospitals, EMS/first responders, law enforcement, and military. Product lines include WoundClot Hospital (surgical and perioperative use) and WoundClot EMS/First Responder formulations. Clinical applications span trauma surgery, plastic surgery, orthopedic procedures (hips, knees, shoulders), foot/ankle surgery, emergency departments, hand/extremity surgery, pacemaker pocket bleeding, wound care, dermatology, and burn management. The gauze is biodegradable, value-priced, easy to apply with minimal training, safe for first responders, stable across temperature ranges (-10°C to 40°C), and effective in austere conditions. The company emphasizes that its team comprises subject matter experts with over a century of combined healthcare experience.

Gamamed Vascular Systems Inc. is a medical device and consumables manufacturer specializing in vascular access solutions for hospitals, clinics, and healthcare centers worldwide. The company's product portfolio encompasses intravenous catheters, advanced central venous access systems, interventional cardiology devices, and wound dressing products. Gamamed's clinical expertise is applied across four primary areas: central venous access, interventional cardiology, IV therapy, and wound care. The company positions itself as a provider of high-performance vascular solutions driven by clinical insight and extensive experience. Products are designed to support critical care, interventional procedures, and standard IV access workflows. Gamamed serves the global healthcare market with an emphasis on quality consumable and device solutions for vascular procedures and therapies.

TIDI Products, LLC is a US-based manufacturer and supplier of single-use medical products and protective solutions for healthcare systems, ambulatory surgery centers, long-term care facilities, and independent practices. The company operates a diversified portfolio of brands including Posey (patient safety and restraints), C-Armor (radiation protection), Sterile-Z (sterilization wraps and drapes), Grip Lok (securement devices), TIDI Shield (protective eyewear and face shields), Zero-Gravity (radiation protection apparel), Aquaguard (shower protection), and Burlington Medical (acquired 2024, expanding safety solutions). Product lines span personal protective equipment (PPE), eyewear, face shields, surgical equipment drapes and covers, falls prevention systems, patient restraints and restraint alternatives, securement devices, medical office and dental office products, shower protection, and home healthcare solutions. TIDI's portfolio addresses caregiver protection through barriers against biological and radiological hazards, and patient safety through fall prevention, contamination control, and dignity-preserving solutions. The company emphasizes clinical collaboration, responsive customer support, and continuing education through TIDI Academy. Headquarters in Neenah, Wisconsin; operates nationwide distribution and rep network.

GelSana Therapeutics develops proprietary zwitterionic wound dressing technology designed to modulate overactive inflammation and support the body's natural wound healing process. The company's flagship product, CleraFlex™, is a stretchable zwitterionic wound dressing indicated for chronic wounds, surgical wounds, and burn injuries. CleraFlex features alternating positive and negative charges that create a protective barrier, calm inflammation, support healthy blood flow, balance moisture levels, and inhibit bacterial adhesion. GelSana targets high-burden chronic wound categories including diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers (PUs), surgical site infections, and acute burns. The company positions its technology as a primary wound dressing capable of replacing most conventional dressing options. GelSana's zwitterionic platform is backed by clinical and scientific validation, addressing wound care applications representing approximately $44 billion in annual U.S. healthcare costs across targeted indications.

Kairos Biosciences is a Salt Lake City, Utah–based regenerative medicine and surgical wound care company focused on enhancing acute surgical recovery. The company develops proprietary collagen and antimicrobial dressing technologies for high-risk surgical and wound environments. Primary product portfolio includes NuForra, a Type I collagen matrix powder featuring AngioReef™ technology with an 80–120 µm pore structure designed to support vascularization in complex surgical wounds, and PurForm AM, a silicone-backed antimicrobial foam dressing containing PHMB (Polyhexamethylene Biguanide) for post-operative wound management. Kairos targets community hospitals, long-term acute care hospitals (LTACHs), VA/DoD facilities, and specialized wound care centers. The company is DOBE-certified (Disabled Owned Business Enterprise), providing procurement advantages for distributor partners. Kairos emphasizes rapid innovation, proprietary formulation science, and patient-first product development with a lean organizational structure.

Gill Podiatry is a specialized medical supplier and distributor serving podiatry practices since 1932. Based in Strongsville, Ohio, the company supplies a comprehensive range of podiatric instruments, consumables, and orthopedic devices. Product lines include surgical instruments (blades, handles, forceps), diagnostic instruments, casting and padding materials, wound care supplies (gauze, bandages, dressings), protective apparel, skin care products, disinfectants, injectables, sutures, and orthopedic appliances. The company also stocks specialty footwear including post-operative shoes (DARCO AllRound, DUO Pro Wound Care), partial foot orthosis walkers, and sandals. Featured products include SafeTPen phenol applicators for precise nail matrix treatment, cryotherapy kits for wart and lesion removal, conforming gauze bandages, and cast padding. Gill maintains an extensive catalog accessible through their online portal with detailed product specifications and pricing. The company serves podiatrists, foot and ankle specialists, and related healthcare practitioners with both consumable supplies and durable medical equipment. The online catalog and product search functionality support professional ordering and account management.

Imbed Biosciences Inc. is a privately held medical device manufacturer headquartered in Middleton, Wisconsin, specializing in advanced wound care solutions. The company develops and markets the SAM™ (Synthetic Antimicrobial Matrix) platform technology—a patented, fully synthetic, biocompatible, bioresorbable matrix designed to integrate multiple wound care agents into an ultra-thin polymer formulation. The SAM™ technology is non-toxic, broad-spectrum antimicrobial through integrated silver, and naturally conforms to wound bed anatomy. Current product portfolio includes Surgaflex™ (acute and surgical wounds), Pelashield™ (burn wounds), and Microlyte® (chronic wounds). Recent portfolio expansion includes SAM™ PainGuard™ variants (Surgaflex™ PainGuard™, Pelashield™ PainGuard™, Microlyte® PainGuard™) that incorporate lidocaine HCl for non-opioid localized pain management alongside antimicrobial protection. Products are indicated for chronic ulcers, surgical wounds, traumatic injuries, and burn wounds across multiple care settings including hospitals, ambulatory surgery centers, physician offices, burn centers, and wound centers. Imbed is registered with the U.S. FDA as a medical device manufacturer and maintains ISO 13485:2016 certification. The company actively supports healthcare providers through education, testimonials, and industry engagement, with recent CMS HCPCS code assignment (A2040) for Microlyte® PainGuard™ enabling standardized billing and claims reporting.

Frontier Therapeutics Inc. is a medical device manufacturer specializing in pressure injury prevention and treatment solutions for hospitals and home care settings. The company's portfolio includes three primary product lines: Repose®, a range of reactive air-filled support surfaces (mattress overlays, foot protectors, heel relief systems, and seating cushions); Dermisplus™ Prevent, a line of gel-based protective pads and tubing designed to redistribute pressure and protect fragile skin from pressure ulcers; and Toto®, an automatic lateral turning system that repositions bedbound patients at regular intervals to mitigate pressure injury risk. Repose® products feature manual pump inflation technology and are suitable for standard, profiling, or domestic beds in both acute and home care environments. Dermisplus™ Prevent items include heel pads, sacral pads, strips for medical device tubing (nasal cannulas, catheters, tracheostomy ties, oxygen masks), and general-use pads for multi-body applications. Toto® is a flat-frame bed-compatible automatic repositioning platform operated via digital control unit (Toto® Touch), designed to turn patients every 2 hours without manual handling by caregivers. All products are marketed for pressure ulcer/injury prevention and treatment in accordance with clinical guidelines from EPUAP, NPIAP, and PPPIA. The company positions its solutions to reduce healthcare costs (pressure injury treatment ranges $21,000–$152,000 per case) and improve quality of care metrics. Products are sold through direct contact and an e-commerce platform (frontierathome.com).

Cork Medical Products, LLC is an Indianapolis-based medical device and support surface manufacturer specializing in wound treatment and prevention solutions. The company designs and manufactures negative pressure wound therapy (NPWT) systems, specialty mattresses, overlays, and wheelchair cushions for acute and chronic wound management. The flagship VERSA negative pressure wound therapy system received the 2025 HME Business New Product Award. Cork Medical's product portfolio addresses pressure ulcer prevention and treatment across hospital, long-term care, and home care settings. The company is ISO 13485:2016 certified and MDSAP compliant, meeting international quality management standards for medical device manufacturing. Products are distributed globally and support clinical outcomes in diverse healthcare settings including acute care facilities, skilled nursing facilities, and homecare environments. Cork Medical manufactures therapeutic support surfaces designed to disperse pressure evenly and promote blood flow, along with specialized wheelchair cushions for mobility assistance and pressure management.